BRKR Stock Declines Despite Launching EpicIF Technology for CellScape [Yahoo! Finance]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Yahoo! Finance
CellScape Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF). The new technology is likely to enhance the CellScape platform by expanding antibody compatibility and doubling throughput while maintaining tissue integrity and lack of cross-reactivity. Following the announcement, shares of the company moved nearly 4.6% south to $57.73 at Friday's close. In the year-to-date period, BRKR shares have plunged 21.5% compared with the industry's decline of 4%. The S&P 500 increased 26.1% in the same time frame. Meanwhile, BRKR currently has a market capitalization of $8.8 billion. Image Source: Zacks Investment Research Launched in 2022, The CellScape Spatial Proteomics Platform is an advanced platform designed to analyze protein expression within cellular contexts, offering high-resolution insights into spatial proteomics. This platform allows researchers to precisely map proteins in tissue samples, which can reveal cell-specific protein patterns, i
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- ANGO Stock Looks Promising on New Ischemia Study for Auryon System [Yahoo! Finance]Yahoo! Finance
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
- AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb IschemiaBusiness Wire
- Endorectal Balloon Market to Witness Remarkable Growth, Reaching US$ 549.7 Million by 2034 at a Strong CAGR of 9.9% | Fact.MR Report [Yahoo! Finance]Yahoo! Finance
- AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAIBusiness Wire
ANGO
Earnings
- 1/8/25 - Beat
ANGO
Analyst Actions
- 12/10/24 - HC Wainwright
ANGO
Sec Filings
- 2/13/25 - Form SCHEDULE
- 2/13/25 - Form SCHEDULE
- 2/5/25 - Form SCHEDULE
- ANGO's page on the SEC website